SOX1 Antibody, IgG by Immunoblot, Serum
Also known as: SOX1 SER
Use
The SOX1 antibody test is useful in assessing patients for Lambert-Eaton myasthenic syndrome (LEMS), paraneoplastic cerebellar degeneration (PCD), or paraneoplastic and nonparaneoplastic neuronopathy. It aids in the detection of associated occult tumors, tumor recurrence, or a second tumor. This test detects the presence of SOX1 antibodies, which are associated with small cell lung cancer.
Special Instructions
Not provided.
Limitations
A negative result does not rule out the presence of Lambert-Eaton myasthenic syndrome or other causes of paraneoplastic neurological syndromes. As this is a qualitative test, it may not quantify the antibody levels accurately. It has not been cleared or approved by the FDA and is for clinical purposes performed in a CLIA-certified laboratory.
New York Approved
Methodology
Immunoassay (Western Blot)
Biomarkers
SOX1 Antibody
Protein
LOINC Codes
- 82444-1 - Glial nuc type 1 Ab Ser Ql Line blot
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.30 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerate after collection. Do not freeze before separation.
Causes for Rejection
Plasma. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Other tests from different labs that may be relevant